Survival Improvements in Adolescents and Young Adults following Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia

Adolescents and young adults (AYAs, ages 15–40 years) with cancer have not experienced survival improvements to the same extent as younger and older patients. We compared changes in survival following myeloablative allogeneic hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wood, William A., Lee, Stephanie J., Brazauskas, Ruta, Wang, Zhiwei, Aljurf, Mahmoud D., Ballen, Karen K., Buchbinder, David K., Dehn, Jason, Freytes, Cesar O., Lazarus, Hillard M., LeMaistre, Charles F., Mehta, Paulette, Szwajcer, David, Joffe, Steven, Majhail, Navneet S.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019683/
https://ncbi.nlm.nih.gov/pubmed/24607554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.02.021
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares